| Rituximab and therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis postkidney transplantation S Alasfar, D Matar, RA Montgomery, N Desai, B Lonze, V Vujjini, ... Transplantation 102 (3), e115-e120, 2018 | 66 | 2018 |
| Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification S Alasfar, N Carter-Monroe, AZ Rosenberg, RA Montgomery, N Alachkar BMC nephrology 17, 1-9, 2016 | 45 | 2016 |
| Pre-transplant screening for non-HLA antibodies: who should be tested? MC Philogene, S Zhou, BE Lonze, S Bagnasco, S Alasfar, ... Human immunology 79 (4), 195-202, 2018 | 43 | 2018 |
| The impact of COVID-19 on kidney transplantation S Alasfar, RK Avery Nature Reviews Nephrology 16 (10), 568-569, 2020 | 39 | 2020 |
| Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature S Alasfar, N Alachkar Frontiers in Medicine 1, 52, 2014 | 36 | 2014 |
| Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection H Alachkar, M Mutonga, T Kato, S Kalluri, Y Kakuta, M Uemura, ... BMC nephrology 17, 1-9, 2016 | 34 | 2016 |
| Recurrent IgA nephropathy after kidney transplantation S Nijim, V Vujjini, S Alasfar, X Luo, B Orandi, C Delp, NM Desai, ... Transplantation proceedings 48 (8), 2689-2694, 2016 | 33 | 2016 |
| The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation BA McMahon, JL Koyner, T Novick, S Menez, RA Moran, BE Lonze, ... Biomarkers 23 (1), 61-69, 2018 | 30 | 2018 |
| ACTH gel in resistant focal segmental glomerulosclerosis after kidney transplantation T Alhamad, JM Dieck, U Younus, D Matar, S Alasfar, V Vujjini, D Wall, ... Transplantation 103 (1), 202-209, 2019 | 25 | 2019 |
| Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab N Alachkar, J Li, D Matar, V Vujjini, S Alasfar, M Tracy, J Reiser, C Wei BMC nephrology 19, 1-8, 2018 | 21 | 2018 |
| Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome–a single center experience S Kant, A Bhalla, S Alasfar, N Alachkar BMC nephrology 21, 1-6, 2020 | 17 | 2020 |
| Outcomes of SOT recipients with COVID-19 in different eras of COVID-19 therapeutics AS Sait, TPY Chiang, KA Marr, AB Massie, W Cochran, P Shah, ... Transplantation direct 8 (1), e1268, 2022 | 15 | 2022 |
| Predictors of renal outcomes in sclerotic class anti-neutrophil cytoplasmic antibody glomerulonephritis S Menez, Z Hruskova, J Scott, S Cormican, M Chen, AD Salama, S Alasfar, ... American Journal of Nephrology 48 (6), 465-471, 2018 | 15 | 2018 |
| Valvular heart disease and dialysis access: a case of cardiac decompensation after fistula creation M Alkhouli, S Alasfar, LA Samuels The Journal of Vascular Access 14 (1), 96-96, 2013 | 15 | 2013 |
| Post-transplant diabetes mellitus in kidney transplant recipients: a multicenter study RF Malik, Y Jia, SG Mansour, PP Reese, IE Hall, S Alasfar, MD Doshi, ... Kidney360 2 (8), 1296-1307, 2021 | 14 | 2021 |
| Renal transplantation in areas of armed conflict S Alasfar, M Isreb, S Kaysi, K Hatahet Seminars in Nephrology 40 (4), 386-392, 2020 | 14 | 2020 |
| Trends in the procurement and discard of kidneys from deceased donors with acute kidney injury C Liu, S Alasfar, PP Reese, S Mohan, MD Doshi, IE Hall, HT Philbrook, ... American Journal of Transplantation 22 (3), 898-908, 2022 | 13 | 2022 |
| Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria M Abuzeineh, A Aala, S Alasfar, N Alachkar BMC nephrology 21, 1-8, 2020 | 12 | 2020 |
| Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation S Alasfar, IE Hall, SG Mansour, Y Jia, HR Thiessen-Philbrook, FL Weng, ... BMC nephrology 22, 1-10, 2021 | 11 | 2021 |
| Complement-based therapy in the management of antibody-mediated rejection A Bhalla, N Alachkar, S Alasfar Advances in Chronic Kidney Disease 27 (2), 138-148, 2020 | 10 | 2020 |
Nada Alachkar, MD.Associate Professor of Medicine. Johns Hopkins University School of MedicineEmail verificata su jhmi.edu
